Kimberly Ann Ozias, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-844-3812 |
Kathryn M Withrow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-231-9042 |
Amanda Mcclain Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 419-902-2987 |
Maria Clary Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-231-9042 |
Laura B Hagan, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10020 Professional Center Dr., Suite 100, Hamburg, MI 48139 Phone: 810-231-6904 |
Prof. Jacquelin Kay Kilburn, OT Occupational Therapist - Neurorehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-231-9042 Fax: 810-231-9063 |
Mrs. Laura Elizabeth Robinson, MS, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-231-9042 |
Catherine Ann Ebbert, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10400 Hamburg Rd, Hamburg, MI 48139 Phone: 810-231-9042 Fax: 810-231-9063 |
News Archive
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
The CHAIT initiative is a public-private partnership focusing on the development of novel immunological therapeutic interventions to achieve a 'functional HIV cure' with the ultimate goal of HIV eradication.
The WHO's March Bulletin is a special themed issue focusing on communicable diseases in Southeast Asia. The publication addresses tuberculosis, cholera, neglected tropical diseases and family planning in the region (March 2010).
A new study from the University of Leicester is investigating whether a naturally produced hormone could provide the key to helping couples conceive.
Ligand Pharmaceuticals Incorporated today announced that multiple clinical studies of dinaciclib (SCH 727965) will be presented by Merck at the upcoming 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4-7, 2010.
› Verified 3 days ago